Neonatal encephalopathy and 3 year outcomes: a French population-based cohort

Area of Science:

• Neonatal neurology
• Developmental pediatrics
• Clinical epidemiology

Background:

• Hypoxic-ischemic encephalopathy (HIE) affects newborns, potentially leading to long-term disability.
• Understanding the rates and factors influencing disability is crucial for early intervention.

Purpose of the Study:

• To assess the rates of neurodevelopmental disability at 3 years in children with HIE.
• To identify factors associated with disability following HIE, including birth circumstances and neonatal complications.

Main Methods:

• A population-based cohort (LyTONEPAL) followed 647 survivors of HIE (Sarnat grades I-III), mostly treated with hypothermia.
• Neurodevelopmental outcomes (mild, moderate, severe) were assessed at 3 years based on motor, sensorial, epilepsy, and developmental delay.
• Relative risk ratios (aRRR) were calculated, adjusted for confounding factors.

Main Results:

• 44.4% of children exhibited some form of neurodevelopmental impairment at 3 years; 10.5% had moderate and 11.8% had severe impairment.
• Abnormal discharge examination and hypoglycemia were associated with increased moderate-to-severe outcomes.
• Hypothermia treatment, higher gestational age, and absence of neonatal infection were associated with better outcomes.

Conclusions:

• Approximately 40% of HIE survivors experience neurodevelopmental sequelae by age 3, with half being mild.
• Factors like neonatal infection and immature brain development negatively impact prognosis, independent of HIE severity.
• Integrating gestational age and neonatal infection into early prognostic assessments, alongside clinical/MRI data, is recommended.